Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience

ABSTRACT: Atrial fibrillation is a common cause of cardiac embolic events, especially stroke. Oral anticoagulation therapy is used to reduce these events. Many patients however are unable to take such therapy. Percutaneous occlusion of the left atrial appendage (the source of 90% of these emboli) is...

Descripción completa

Detalles Bibliográficos
Autor principal: Abelson, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2013
Materias:
Cardiovascular Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721860/
https://www.ncbi.nlm.nih.gov/pubmed/24217039
http://dx.doi.org/10.5830/CVJA-2013-018
_version_ 1782278096781574144
author Abelson, Mark
author_facet Abelson, Mark
author_sort Abelson, Mark
collection PubMed
description ABSTRACT: Atrial fibrillation is a common cause of cardiac embolic events, especially stroke. Oral anticoagulation therapy is used to reduce these events. Many patients however are unable to take such therapy. Percutaneous occlusion of the left atrial appendage (the source of 90% of these emboli) is an option in these patients. Presented here are the first 12 patients to have this procedure done in South Africa.
format Online
Article
Text
id pubmed-3721860
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Clinics Cardive Publishing
record_format MEDLINE/PubMed
spelling pubmed-37218602013-08-07 Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience Abelson, Mark Cardiovasc J Afr Cardiovascular Topics ABSTRACT: Atrial fibrillation is a common cause of cardiac embolic events, especially stroke. Oral anticoagulation therapy is used to reduce these events. Many patients however are unable to take such therapy. Percutaneous occlusion of the left atrial appendage (the source of 90% of these emboli) is an option in these patients. Presented here are the first 12 patients to have this procedure done in South Africa. Clinics Cardive Publishing 2013-06 /pmc/articles/PMC3721860/ /pubmed/24217039 http://dx.doi.org/10.5830/CVJA-2013-018 Text en Copyright © 2010 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cardiovascular Topics
Abelson, Mark
Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
title Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
title_full Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
title_fullStr Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
title_full_unstemmed Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
title_short Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
title_sort left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial south african experience
topic Cardiovascular Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721860/
https://www.ncbi.nlm.nih.gov/pubmed/24217039
http://dx.doi.org/10.5830/CVJA-2013-018
work_keys_str_mv AT abelsonmark leftatrialappendageclosureinpatientswithatrialfibrillationinwhomwarfariniscontraindicatedinitialsouthafricanexperience

Ejemplares similares